Meg Jardine @[email protected]
@jardine_meg
Followers
1K
Following
1K
Statuses
363
Director NHMRC Clinical Trials Centre, Professor of Medicine, Nephrologist, Trialist
Sydney, New South Wales
Joined April 2019
Truly inspirational. Wonderful to hear some of the insights on trial that saved a million lives in a year. A tribute to the many different organisations involved. Can we harness this same collaborative approach to addressing the epidemic of chronic disease?
What does it take to revolutionise COVID-19 treatment? Yesterday, we found out! We hosted Prof. @RichardHaynes3, who shared insights from the #RECOVERYTrial, the world’s largest #COVID19 treatment trial. His exploration of the trial’s design, methodology, and key findings was enlightening. Thank you, Richard, for an inspiring session!
0
1
9
Great summary of clinical effects, mechanisms of action and health economic evaluations led by @Daniel_V_OHara
Applications of SGLT2 inhibitors beyond glycaemic control from @jardine_meg and colleagues
0
3
11
RT @ISNkidneycare: 📢 Call for Nominations Nominate the next ISN: 👤President-Elect & 👥Regional Board Deputy Chairs/Council members for all…
0
4
0
RT @KidneyHealth: The only way to slow down #kidneydisease is to catch it early, before symptoms appear. Take the 2min risk test online no…
0
7
0
RT @CJASN: Angiopoietin 2 regulates endothelial function partially mediated by VEGF-A. This study found higher angiopoietin 2 levels were a…
0
5
0
@TrialsCentre Fantastic summary of a field that has exploded. Great work from #ISN Emerging Leader Program Fellow, #ISN-ELP, @Daniel_V_OHara
0
1
4
RT @TrialsCentre: 📢 Prepare for the new treatment landscape 📢 #SGLT2 inhibitors are foundational for prevention & treatment of complicatio…
0
2
0
RT @RachaelMorton12: Did you know the NHMRC @TrialsCentre is now conducting 20 adaptive platform trials. Congratulations to all academic an…
0
2
0
@TrialsCentre @KristyRobledo @david_j_beard @nhmrc Well done @KristyRobledo and @david_j_beard! Exciting times ahead!
0
0
6
Had a fantastic time at the InaSN meeting discussing the latest #KDIGO_CKD_Guidelines. With new therapies, access & implementation now a key focus. @NephJC will also be discussing - online May 21/22 Thanks to Dr Pringgo & team for a warm welcome and to #ISN for support
Huge thanks to Prof. @jardine_meg for her enlightening talk on the latest KDIGO CKD guidelines at the 23rd Jakarta Nephrology and Hypertension Course, hosted by the Indonesia Society of Nephrology. The event in Jakarta was a success, enhanced by the support of ISN and KDIGO.
0
2
13
Always fun and informative to chat with Rajiv!
NEW PODCAST 📻 Catch up on the #ASN2023 highlights with Professors @Jardine_Meg and @AgarwalRajivMD over on the CMF! Access here via soundcloud: Access here via youtube:
0
0
2
An exciting time for kidney disease with lots of new therapies on the horizon. #KidneyHealthForAll is a timely reminder that we need to ensure equitable access as these emerge @ISNkidneycare; @KidneyHealth
@KidneyHealthIn
Happy #WorldKidneyDay! This year's theme is #KidneyHealthForAll: Advancing Equitable Access to Care and Optimal Medication Practice. We're working towards a future where everyone has access to quality care for their kidneys. 💪🏽👨🏼⚕️👩🏾⚕️ Learn more here:
1
2
15
RT @JASN_News: Excess mortality in HD patients is associated with abnormal fluid status and plasma sodium concentrations. This study stress…
0
5
0
Thank-you! Including first author @brendanjsmyth. Worth reading the original article led by @JulePinter Challenging - observational evidence is confounded & can be difficult to interpret. An eg of where randomisation is needed for true quality assessment
1
0
4
@TrialsCentre @ISNkidneycare @Sydney_Uni @Daniel_V_OHara @MelanieWyl22998 @UNSW Congratulations to all the cohort. It's a great program!
0
1
1
@so_jcc Disappointingly little proven evidence for calciphylaxis. It's why trials are so important. I'm not aware of a registry in the US. @sagarnigs may know more
3
1
1
That can be a challenge. The concept is - will receive one of a number of interventions or placebo. If not getting better after 4 weeks, will get an active treatment (but you won't know which one). #NephTrials
0
1
5